Drug Trial Radar · NCT07932002
Exploring the Extended Efficacy and Initial Use of RUCONEST® in Managing Neurological Symptoms Linked to Infectious Pathogens
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
30
Planned (sponsor's estimate)
Start
Nov 5, 2025
Primary completion
Jul 31, 2027
Study completion Oct 29, 2027
Sponsor
- Lead sponsor
- IMMUNOe Research CentersIndustry
- Sponsor type
- Industry
- First posted
- Nov 12, 2026
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Assessment of RUCONEST (C1 Esterase Inhibitor \[Recombinant\]) in Alleviating Neurological Symptoms Linked to Infectious Pathogens
Conditions
- Post SARS-CoV2 (COVID-19)
- Post-Viral Fatigue Syndrome
- Post-Viral Disorder (Disorder)
- COVID - 19
Interventions
RuconestDrug
IV Ruconest
Primary outcomes
What the sponsor says the trial is designed to measure.
- Neuropsychological Measures (BRIEF-A)Time frame: Week 0
- Neuropsychological Measures (BRIEF-A)Time frame: Week 5
- Neuropsychological Measures (BRIEF-A)Time frame: Week 9
- Neuropsychological Measures (BRIEF-A)Time frame: Week 13
- Neuropsychological Measures (BRIEF-A)Time frame: Week 17
- Neuropsychological Measures (BRIEF-A)Time frame: Week 21
- Neuropsychological Measures (BRIEF-A)Time frame: Week 25
- Neuropsychological Measures (RBANS)Time frame: Week 0
- Neuropsychological Measures (RBANS)Time frame: Week 5
- Neuropsychological Measures (RBANS)Time frame: Week 9
- Neuropsychological Measures (RBANS)Time frame: Week 13
- Neuropsychological Measures (RBANS)Time frame: Week 17
- Neuropsychological Measures (RBANS)Time frame: Week 21
- Neuropsychological Measures (RBANS)Time frame: Week 25
- Neuropsychological Measures (BDI II)Time frame: Week 0
- Neuropsychological Measures (BDI II)Time frame: Week 5
- Neuropsychological Measures (BDI II)Time frame: Week 9
- Neuropsychological Measures (BDI II)Time frame: Week 13
- Neuropsychological Measures (BDI II)Time frame: Week 17
- Neuropsychological Measures (BDI II)Time frame: Week 21
- Neuropsychological Measures (BDI II)Time frame: Week 25
- Neuropsychological Measures (MoCA)Time frame: Week 0
- Neuropsychological Measures (MoCA)Time frame: Week 5
- Neuropsychological Measures (MoCA)Time frame: Week 9
- Neuropsychological Measures (MoCA)Time frame: Week 13
- Neuropsychological Measures (MoCA)Time frame: Week 17
- Neuropsychological Measures (MoCA)Time frame: Week 21
- Neuropsychological Measures (MoCA)Time frame: Week 25
- Patient-Rated Questionnaire (FSS)Time frame: Week 0
- Patient-Rated Questionnaire (FSS)Time frame: Week 5
- Patient-Rated Questionnaire (FSS)Time frame: Week 9
- Patient-Rated Questionnaire (FSS)Time frame: Week 13
- Patient-Rated Questionnaire (FSS)Time frame: Week 17
- Patient-Rated Questionnaire (FSS)Time frame: Week 21
- Patient-Rated Questionnaire (FSS)Time frame: Week 25
- Patient-Rated Questionnaire (MIDAS)Time frame: Week 0
- Patient-Rated Questionnaire (MIDAS)Time frame: Week 5
- Patient-Rated Questionnaire (MIDAS)Time frame: Week 9
- Patient-Rated Questionnaire (MIDAS)Time frame: Week 13
- Patient-Rated Questionnaire (MIDAS)Time frame: Week 17
- Patient-Rated Questionnaire (MIDAS)Time frame: Week 21
- Patient-Rated Questionnaire (MIDAS)Time frame: Week 25
- Patient-Rated Questionnaire (HIT)Time frame: Week 0
- Patient-Rated Questionnaire (HIT)Time frame: Week 5
- Patient-Rated Questionnaire (HIT)Time frame: Week 9
- Patient-Rated Questionnaire (HIT)Time frame: Week 13
- Patient-Rated Questionnaire (HIT)Time frame: Week 17
- Patient-Rated Questionnaire (HIT)Time frame: Week 21
- Patient-Rated Questionnaire (HIT)Time frame: Week 25
- Patient-Rated Questionnaire (Activities)Time frame: Week 0
- Patient-Rated Questionnaire (Activities)Time frame: Week 5
- Patient-Rated Questionnaire (Activities)Time frame: Week 9
- Patient-Rated Questionnaire (Activities)Time frame: Week 13
- Patient-Rated Questionnaire (Activities)Time frame: Week 17
- Patient-Rated Questionnaire (Activities)Time frame: Week 21
- Patient-Rated Questionnaire (Activities)Time frame: Week 25
- Patient-Rated Questionnaire (SF)Time frame: Week 0
- Patient-Rated Questionnaire (SF)Time frame: Week 5
- Patient-Rated Questionnaire (SF)Time frame: Week 9
- Patient-Rated Questionnaire (SF)Time frame: Week 13
- Patient-Rated Questionnaire (SF)Time frame: Week 17
- Patient-Rated Questionnaire (SF)Time frame: Week 21
- Patient-Rated Questionnaire (SF)Time frame: Week 25
- Patient-Rated Questionnaire (GSRS)Time frame: Week 0
- Patient-Rated Questionnaire (GSRS)Time frame: Week 5
- Patient-Rated Questionnaire (GSRS)Time frame: Week 9
- Patient-Rated Questionnaire (GSRS)Time frame: Week 13
- Patient-Rated Questionnaire (GSRS)Time frame: Week 17
- Patient-Rated Questionnaire (GSRS)Time frame: Week 21
- Patient-Rated Questionnaire (GSRS)Time frame: Week 25
- Patient-Rated Questionnaire (SF-36)Time frame: Week 0
- Patient-Rated Questionnaire (SF-36)Time frame: Week 5
- Patient-Rated Questionnaire (SF-36)Time frame: Week 9
- Patient-Rated Questionnaire (SF-36)Time frame: Week 13
- Patient-Rated Questionnaire (SF-36)Time frame: Week 17
- Patient-Rated Questionnaire (SF-36)Time frame: Week 21
- Patient-Rated Questionnaire (SF-36)Time frame: Week 25
- Neurological ExamTime frame: Week 0
- Neurological ExamTime frame: Week 5
- Neurological ExamTime frame: Week 9
- Neurological ExamTime frame: Week 13
- Neurological ExamTime frame: Week 17
- Neurological ExamTime frame: Week 21
- Neurological ExamTime frame: Week 25
Locations
1 site in 1 country. Site status is shown where the registry gives one.
IMMUNOe Research Centers
Centennial, Colorado · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.